Skip to Main Content
Table 1

Clinical properties of maspin and p63 in NSCLC tissues

Cytoplasmic maspinNuclear p63
Present (n = 28)Absent (n = 19)P              *Present (n = 18)Absent (n = 29)P              *
Stage   0.186   0.482 
 1 16 8  9 15  
 2 5 8  6 7  
 3 7 3  6 4  
Histology   <0.001   <0.001 
 Adenocarcinoma 4 15  2 17  
 Squamous cell carcinoma 13 0  13 0  
 Others 11 4  6 9  
Cytoplasmic maspinNuclear p63
Present (n = 28)Absent (n = 19)P              *Present (n = 18)Absent (n = 29)P              *
Stage   0.186   0.482 
 1 16 8  9 15  
 2 5 8  6 7  
 3 7 3  6 4  
Histology   <0.001   <0.001 
 Adenocarcinoma 4 15  2 17  
 Squamous cell carcinoma 13 0  13 0  
 Others 11 4  6 9  
*

χ2 test.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept